These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 27872016)
1. Tuberculosis eradication versus control. Schito M; Hanna D; Zumla A Int J Infect Dis; 2017 Mar; 56():10-13. PubMed ID: 27872016 [TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
3. Shifting from tuberculosis control to elimination: Where are we? What are the variables and limitations? Is it achievable? Centis R; D'Ambrosio L; Zumla A; Migliori GB Int J Infect Dis; 2017 Mar; 56():30-33. PubMed ID: 27916675 [TBL] [Abstract][Full Text] [Related]
4. Tuberculosis: a new vision for the 21st century. Small PM Kekkaku; 2009 Nov; 84(11):721-6. PubMed ID: 19999594 [TBL] [Abstract][Full Text] [Related]
5. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [TBL] [Abstract][Full Text] [Related]
6. [Recent progress in mycobacteriology]. Okada M; Kobayashi K Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602 [TBL] [Abstract][Full Text] [Related]
8. Can China achieve the WHO global targets for TB control by 2035? Huynh GH Trans R Soc Trop Med Hyg; 2016 Mar; 110(3):161-2. PubMed ID: 26884495 [TBL] [Abstract][Full Text] [Related]
9. Drug-resistant TB: deadly, costly and in need of a vaccine. Manjelievskaia J; Erck D; Piracha S; Schrager L Trans R Soc Trop Med Hyg; 2016 Mar; 110(3):186-91. PubMed ID: 26884499 [TBL] [Abstract][Full Text] [Related]
10. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force. Centers for Disease Control and Prevention (CDC) MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162 [TBL] [Abstract][Full Text] [Related]
12. [Fight against tuberculosis in the world]. El Kamel A; Joobeur S; Skhiri N; Cheikh Mhamed S; Mribah H; Rouatbi N Rev Pneumol Clin; 2015; 71(2-3):181-7. PubMed ID: 24878188 [TBL] [Abstract][Full Text] [Related]
13. New Drugs and Vaccines for Tuberculosis. Gaur PK; Mishra S Recent Pat Antiinfect Drug Discov; 2017; 12(2):147-161. PubMed ID: 28990539 [TBL] [Abstract][Full Text] [Related]
14. TB control: challenges and opportunities for India. Pai M; Daftary A; Satyanarayana S Trans R Soc Trop Med Hyg; 2016 Mar; 110(3):158-60. PubMed ID: 26884494 [TBL] [Abstract][Full Text] [Related]
16. Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis. Mwaba P; McNerney R; Grobusch MP; O'Grady J; Bates M; Kapata N; Maeurer M; Zumla A Trop Med Int Health; 2011 Jul; 16(7):819-27. PubMed ID: 21489070 [TBL] [Abstract][Full Text] [Related]
17. Investing to end epidemics: the role of the Global Fund to control TB by 2030. Kunii O; Yassin MA; Wandwalo E Trans R Soc Trop Med Hyg; 2016 Mar; 110(3):153-4. PubMed ID: 26884492 [TBL] [Abstract][Full Text] [Related]
18. Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment. Lange C; Chesov D; Heyckendorf J; Leung CC; Udwadia Z; Dheda K Respirology; 2018 Jul; 23(7):656-673. PubMed ID: 29641838 [TBL] [Abstract][Full Text] [Related]
19. Clinical tuberculosis problems and management. Amin Z Acta Med Indones; 2006; 38(2):109-16. PubMed ID: 16799215 [TBL] [Abstract][Full Text] [Related]
20. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control. Fears R; Kaufmann S; Ter Meulen V; Zumla A; Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]